A detailed history of Agf Management LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Agf Management LTD holds 8,964 shares of UTHR stock, worth $3.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,964
Holding current value
$3.27 Million
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $2.79 Million - $3.26 Million
8,964 New
8,964 $3.21 Million
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $2.28 Million - $2.7 Million
-10,822 Reduced 91.67%
984 $226,000
Q4 2023

Feb 07, 2024

SELL
$214.88 - $256.94 $340,584 - $407,249
-1,585 Reduced 11.84%
11,806 $2.6 Million
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $572,125 - $670,496
-2,701 Reduced 16.78%
13,391 $3.02 Million
Q2 2023

Aug 09, 2023

BUY
$205.19 - $232.99 $462,703 - $525,392
2,255 Added 16.3%
16,092 $3.55 Million
Q1 2023

May 03, 2023

BUY
$212.99 - $276.17 $2.95 Million - $3.82 Million
13,837 New
13,837 $3.1 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Agf Management LTD Portfolio

Follow Agf Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Agf Management LTD with notifications on news.